Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
The latest trading day saw Novavax (NVAX) settling at $8.67, representing a +1.17% change from its previous close.
Zacks·2d ago
More News
Novavax Amends Deal With Sanofi, Broadens Partnership
The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.
Stocktwits·2d ago
Here's Why Novavax (NVAX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·6d ago
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks·7d ago
Novavax (NVAX) Declines More Than Market: Some Information for Investors
Novavax (NVAX) concluded the recent trading session at $8.68, signifying a -2.2% move from its prior day's close.
Zacks·9d ago
Here's Why Novavax (NVAX) Fell More Than Broader Market
Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.
Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the LP.8.1 COVID-19 variant in phase IV study.
Zacks·15d ago
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.
Zacks·17d ago
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·22d ago
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda
The vaccine was approved for initial immunization in individuals aged six years or older and as a booster immunization in those aged 12 years or older in the country.